Arnold, M. et al. Global patterns and trends in colorectal cancer incidence and mortality. Gut 66, 683–691 (2017).
GBD 2019 Colorectal Cancer Collaborators.Global, regional, and national burden of colorectal cancer and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol. Hepatol. 7, 627–647 (2022).
Douaiher, J. et al. Colorectal cancer—global burden, trends, and geographical variations. J. Surg. Oncol. 115, 619–630 (2017).
IHME Data. Global Burden of Disease Study 2019 (GBD 2019) data resources. GHDx https://ghdx.healthdata.org/gbd-2019 (2019).
Siegel, R. L. et al. Global patterns and trends in colorectal cancer incidence in young adults. Gut 68, 2179–2185 (2019).
Siegel, R. L. et al. Colorectal cancer incidence patterns in the United States, 1974–2013. J. Natl Cancer Inst. 109, djw322 (2017).
Akimoto, N. et al. Rising incidence of early-onset colorectal cancer — a call to action. Nat. Rev. Clin. Oncol. 18, 230–243 (2021).
Sinicrope, F. A. Increasing incidence of early-onset colorectal cancer. N. Engl. J. Med. 386, 1547–1558 (2022).
Patel, S. G., Karlitz, J. J., Yen, T., Lieu, C. H. & Boland, C. R. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection. Lancet Gastroenterol. Hepatol. 7, 262–274 (2022).
Ugai, T. et al. Is early-onset cancer an emerging global epidemic? Current evidence and future implications. Nat. Rev. Clin. Oncol. 19, 656–673 (2022).
Knudsen, A. B. et al. Colorectal cancer screening: an updated modeling study for the US preventive services task force. JAMA 325, 1998–2011 (2021).
Stoffel, E. M. et al. Germline genetic features of young individuals with colorectal cancer. Gastroenterology 154, 897–905.e891 (2018).
Pearlman, R. et al. Prevalence and spectrum of germline cancer susceptibility gene mutations among patients with early-onset colorectal cancer. JAMA Oncol. 3, 464–471 (2017).
Lee, J. K. et al. Rising early-onset colorectal cancer incidence is not an artifact of increased screening colonoscopy use in a large, diverse healthcare system. Gastroenterology 162, 325–327.e323 (2022).
Keum, N. & Giovannucci, E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat. Rev. Gastroenterol. Hepatol. 16, 713–732 (2019).
Hofseth, L. J. et al. Early-onset colorectal cancer: initial clues and current views. Nat. Rev. Gastroenterol. Hepatol. 17, 352–364 (2020).
Murphy, C. C., Singal, A. G., Baron, J. A. & Sandler, R. S. Decrease in incidence of young-onset colorectal cancer before recent increase. Gastroenterology 155, 1716–1719.e4 (2018).
SEER. Surveillance, Epidemiology, and End Results (SEER) Program. SEER https://seer.cancer.gov/data-software/documentation/seerstat/nov2022/ (2023).
Siegel, R. L., Medhanie, G. A., Fedewa, S. A. & Jemal, A. State variation in early-onset colorectal cancer in the United States, 1995–2015. J. Natl Cancer Inst. 111, 1104–1106 (2019).
Abdelsattar, Z. M. et al. Colorectal cancer outcomes and treatment patterns in patients too young for average-risk screening. Cancer 122, 929–934 (2016).
Rho, Y. S. et al. Comparing clinical characteristics and outcomes of young-onset and late-onset colorectal cancer: an international collaborative study. Clin. Colorectal Cancer 16, 334–342 (2017).
Patel, S. G. & Ahnen, D. J. Colorectal cancer in the young. Curr. Gastroenterol. Rep. 20, 15 (2018).
Cercek, A. et al. A comprehensive comparison of early-onset and average-onset colorectal cancers. J. Natl Cancer Inst. 113, 1683–1692 (2021).
Chang, D. T. et al. Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features. Mod. Pathol. 25, 1128–1139 (2012).
Murphy, C. C. et al. Patterns of sociodemographic and clinicopathologic characteristics of stages ii and iii colorectal cancer patients by age: examining potential mechanisms of young-onset disease. J. Cancer Epidemiol. 2017, 4024580 (2017).
Di Leo, M. et al. Risk factors and clinical characteristics of early-onset colorectal cancer vs. late-onset colorectal cancer: a case-case study. Eur. J. Gastroenterol. Hepatol. 33, 1153–1160 (2020).
Gausman, V. et al. Risk factors associated with early-onset colorectal cancer. Clin. Gastroenterol. Hepatol. 18, 2752–2759.e2752 (2020).
Chang, V. C., Cotterchio, M., De, P. & Tinmouth, J. Risk factors for early-onset colorectal cancer: a population-based case-control study in Ontario, Canada. Cancer Causes Control 33, 1063–1083 (2021).
Griffiths, C. D. et al. Presentation and survival among patients with colorectal cancer before the age of screening: a systematic review and meta-analysis. Can. J. Surg. 64, E91–E100 (2021).
Archambault, A. N. et al. Cumulative burden of colorectal cancer-associated genetic variants is more strongly associated with early-onset vs late-onset cancer. Gastroenterology 158, 1274–1286.e1212 (2020).
Murphy, C. C., Wallace, K., Sandler, R. S. & Baron, J. A. Racial disparities in incidence of young-onset colorectal cancer and patient survival. Gastroenterology 156, 958–965 (2019).
World Cancer Research Fund/American Institute for Cancer Research. Diet, nutrition, physical activity and colorectal cancer. World Cancer Research Fund https://www.wcrf.org/wp-content/uploads/2021/02/Colorectal-cancer-report.pdf (2018).
Kim, H., Wang, K., Song, M. & Giovannucci, E. L. A comparison of methods in estimating population attributable risk for colorectal cancer in the United States. Int. J. Cancer 148, 2947–2953 (2021).
Brenner, D. R. et al. Increasing colorectal cancer incidence trends among younger adults in Canada. Prev. Med. 105, 345–349 (2017).
Feletto, E. et al. Trends in colon and rectal cancer incidence in Australia from 1982 to 2014: analysis of data on over 375,000 cases. Cancer Epidemiol. Biomark. Prev. 28, 83–90 (2019).
Chung, R. Y. et al. A population-based age-period-cohort study of colorectal cancer incidence comparing Asia against the West. Cancer Epidemiol. 59, 29–36 (2019).
Zheng, T. et al. Time trend and the age-period-cohort effect on the incidence of histologic types of lung cancer in Connecticut, 1960–1989. Cancer 74, 1556–1567 (1994).
Jemal, A., Chu, K. C. & Tarone, R. E. Recent trends in lung cancer mortality in the United States. J. Natl Cancer Inst. 93, 277–283 (2001).
Anderson, W. F. et al. Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA 303, 1723–1728 (2010).
Anderson, W. F. et al. The changing face of noncardia gastric cancer incidence among US non-hispanic whites. J. Natl Cancer Inst. 110, 608–615 (2018).
Pinheiro, P. S. et al. Liver cancer: a leading cause of cancer death in the United States and the role of the 1945–1965 birth cohort by ethnicity. JHEP Rep. 1, 162–169 (2019).
Clarke, M. A. & Joshu, C. E. Early life exposures and adult cancer risk. Epidemiol. Rev. 39, 11–27 (2017).
Wild, C. P. How much of a contribution do exposures experienced between conception and adolescence make to the burden of cancer in adults? Cancer Epidemiol. Biomark. Prev. 20, 580–581 (2011).
Tomatis, L. Overview of perinatal and multigeneration carcinogenesis. IARC Sci. Publ. (96), 1–15 (1989).
Cohn, B. A. et al. DDT exposure in utero and breast cancer. J. Clin. Endocrinol. Metab. 100, 2865–2872 (2015).
Cohn, B. A., Cirillo, P. M. & Christianson, R. E. Prenatal DDT exposure and testicular cancer: a nested case–control study. Arch. Env. Occup. Health 65, 127–134 (2010).
Preston, D. L. et al. Cancer incidence in atomic bomb survivors. Part III: leukemia, lymphoma and multiple myeloma, 1950–1987. Radiat. Res. 137, S68–S97 (1994).
Preston, D. L. et al. Solid cancer incidence in atomic bomb survivors exposed in utero or as young children. J. Natl Cancer Inst. 100, 428–436 (2008).
Vedham, V., Verma, M. & Mahabir, S. Early‐life exposures to infectious agents and later cancer development. Cancer Med. 4, 1908–1922 (2015).
van den Berg, B. The California child health and development studies. Handb. Longitud. Res. 1, 166–179 (1984).
van den Berg, B. J., Christianson, R. E. & Oechsli, F. W. The California child health and development studies of the School of Public Health, University of California at Berkeley. Paediatr. Perinat. Epidemiol. 2, 265–282 (1988).
Lehtinen, M., Surcel, H. M., Natunen, K., Pukkala, E. & Dillner, J. Cancer registry follow-up for 17 million person-years of a nationwide maternity cohort. Cancer Med. 6, 3060–3064 (2017).
Wadsworth, M., Kuh, D., Richards, M. & Hardy, R. Cohort profile: the 1946 national birth cohort (MRC National Survey of Health and Development). Int. J. Epidemiol. 35, 49–54 (2006).
Power, C. & Elliott, J. Cohort profile: 1958 British birth cohort (National Child Development Study). Int. J. Epidemiol. 35, 34–41 (2006).
Sullivan, A., Brown, M., Hamer, M. & Ploubidis, G. B. Cohort profile update: the 1970 British Cohort Study (BCS70). Int. J. Epidemiol. 35, 836–843 (2022).
Lessof, C., Ross, A., Brind, R., Bell, E. & Newton, S. Longitudinal study of young people in England cohort 2: health and wellbeing at wave 2. gov.uk https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/599871/LSYPE2_w2-research_report.pdf (2016).
Barker, D. J., Osmond, C., Thornburg, K. L., Kajantie, E. & Eriksson, J. G. The shape of the placental surface at birth and colorectal cancer in later life. Am. J. Hum. Biol. 25, 566–568 (2013).
Cnattingius, S., Lundberg, F. & Iliadou, A. Birth characteristics and risk of colorectal cancer: a study among Swedish twins. Br. J. Cancer 100, 803–806 (2009).
Ahlgren, M., Wohlfahrt, J., Olsen, L. W., Sørensen, T. I. & Melbye, M. Birth weight and risk of cancer. Cancer 110, 412–419 (2007).
McCormack, V. A., dos Santos Silva, I., Koupil, I., Leon, D. A. & Lithell, H. O. Birth characteristics and adult cancer incidence: Swedish cohort of over 11,000 men and women. Int. J. Cancer 115, 611–617 (2005).
Nilsen, T. I., Romundstad, P. R., Troisi, R., Potischman, N. & Vatten, L. J. Birth size and colorectal cancer risk: a prospective population based study. Gut 54, 1728–1732 (2005).
Smith, N. R. et al. Associations between birth weight and colon and rectal cancer risk in adulthood. Cancer Epidemiol. 42, 181–185 (2016).
Spracklen, C. N. et al. Birth weight and subsequent risk of cancer. Cancer Epidemiol. 38, 538–543 (2014).
Yang, T. O., Reeves, G. K., Green, J., Beral, V. & Cairns, B. J. Birth weight and adult cancer incidence: large prospective study and meta-analysis. Ann. Oncol. 25, 1836–1843 (2014).
Sandhu, M. S., Luben, R., Day, N. E. & Khaw, K. T. Self-reported birth weight and subsequent risk of colorectal cancer. Cancer Epidemiol. Biomark. Prev. 11, 935–938 (2002).
Murphy, C. C. et al. Maternal obesity, pregnancy weight gain, and birth weight and risk of colorectal cancer. Gut 71, 2611–2612 (2021).
Murphy, C. C., Cirillo, P. M., Krigbaum, N. Y. & Cohn, B. A. In utero exposure to 17α-hydroxyprogesterone caproate and risk of cancer in offspring. Am. J. Obstet. Gynecol. 226, 132.e1–132.e14 (2021).
Murphy, C. C., Cirillo, P. M., Krigbaum, N. Y., Singal, A. G. & Cohn, B. A. In utero exposure to anti-emetic and risk of adult-onset colorectal cancer. JNCI Cancer Spectr. 7, pkad021 (2023).
Murphy, C. C. et al. In-utero exposure to antibiotics and risk of colorectal cancer in a prospective cohort of 18000 adult offspring. Int. J. Epidemiol. 24, dyad004 (2023).
Liu, P. H. et al. Association of obesity with risk of early-onset colorectal cancer among women. JAMA Oncol. 5, 37–44 (2019).
Nimptsch, K. et al. Body fatness during childhood and adolescence, adult height, and risk of colorectal adenoma in women. Cancer Prev. Res. 4, 1710–1718 (2011).
Li, H. et al. Associations of body mass index at different ages with early-onset colorectal cancer. Gastroenterology 162, 1088–1097.e1083 (2022).
Jensen, B. W. et al. Childhood body mass index and height in relation to site-specific risks of colorectal cancers in adult life. Eur. J. Epidemiol. 32, 1097–1106 (2017).
Celind, J., Ohlsson, C., Bygdell, M., Nethander, M. & Kindblom, J. M. Childhood body mass index is associated with risk of adult colon cancer in men – an association modulated by pubertal change in body mass index. Cancer Epidemiol. Biomark. Prev. 28, 974–979 (2019).
Bjørge, T., Engeland, A., Tverdal, A. & Smith, G. D. Body mass index in adolescence in relation to cause-specific mortality: a follow-up of 230,000 Norwegian adolescents. Am. J. Epidemiol. 168, 30–37 (2008).
Burton, A., Martin, R., Galobardes, B., Davey Smith, G. & Jeffreys, M. Young adulthood body mass index and risk of cancer in later adulthood: historical cohort study. Cancer Causes Control 21, 2069–2077 (2010).
Nimptsch, K. & Wu, K. Is timing important? the role of diet and lifestyle during early life on colorectal neoplasia. Curr. Colorectal Cancer Rep. 14, 1–11 (2018).
Garcia, H. & Song, M. Early-life obesity and adulthood colorectal cancer risk: a meta-analysis. Rev. Panam. Salud Publica 43, e3 (2019).
Moghaddam, A. A., Woodward, M. & Huxley, R. Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol. Biomark. Prev. 16, 2533–2547 (2007).
Larsson, S. C. & Wolk, A. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am. J. Clin. Nutr. 86, 556–565 (2007).
Bardou, M., Barkun, A. N. & Martel, M. Obesity and colorectal cancer. Gut 62, 933–947 (2013).
Godfrey, K. M. & Barker, D. J. Fetal programming and adult health. Public Health Nutr. 4, 611–624 (2001).
Shankar, K. et al. Maternal obesity at conception programs obesity in the offspring. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294, R528–R538 (2008).
Curhan, G. C. et al. Birth weight and adult hypertension and obesity in women. Circulation 94, 1310–1315 (1996).
Armitage, J. A., Poston, L. & Taylor, P. D. Developmental origins of obesity and the metabolic syndrome: the role of maternal obesity. Front. Horm. Res. 36, 73–84 (2008).
Larsson, S. C., Orsini, N. & Wolk, A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J. Natl Cancer Inst. 97, 1679–1687 (2005).
Nimptsch, K. et al. Dietary intakes of red meat, poultry, and fish during high school and risk of colorectal adenomas in women. Am. J. Epidemiol. 178, 172–183 (2013).
Nimptsch, K. et al. Dairy intake during adolescence and risk of colorectal adenoma later in life. Br. J. Cancer 124, 1160–1168 (2021).
Hur, J. et al. Sugar-sweetened beverage intake in adulthood and adolescence and risk of early-onset colorectal cancer among women. Gut 70, 2330–2336 (2021).
Joh, H.-K. et al. Simple sugar and sugar-sweetened beverage intake during adolescence and risk of colorectal cancer precursors. Gastroenterology 161, 128–142. e120 (2021).
Nimptsch, K. et al. Dietary patterns during high school and risk of colorectal adenoma in a cohort of middle-aged women. Int. J. Cancer 134, 2458–2467 (2014).
Dirx, M. J., van den Brandt, P. A., Goldbohm, R. A. & Lumey, L. Energy restriction early in life and colon carcinoma risk: results of the Netherlands Cohort Study after 7.3 years of follow‐up. Cancer 97, 46–55 (2003).
Cao, Y. et al. Long-term use of antibiotics and risk of colorectal adenoma. Gut 67, 672–678 (2018).
Molmenti, C. L. S., Jacobs, E. T., Gupta, S. & Thomson, C. A. Early-onset colorectal cancer: a call for greater rigor in epidemiologic studies. Cancer Epidemiol. Biomark. Prev. 31, 507–511 (2022).
Dasu, K., Xia, X., Siriwardena, D., Klupinski, T. P. & Seay, B. Concentration profiles of per- and polyfluoroalkyl substances in major sources to the environment. J. Env. Manag. 301, 113879 (2022).
Prevedouros, K., Cousins, I. T., Buck, R. C. & Korzeniowski, S. H. Sources, fate and transport of perfluorocarboxylates. Env. Sci. Technol. 40, 32–44 (2006).
Temkin, A. M., Hocevar, B. A., Andrews, D. Q., Naidenko, O. V. & Kamendulis, L. M. Application of the key characteristics of carcinogens to per and polyfluoroalkyl substances. Int. J. Environ. Res. Public Health 17, 1668 (2020).
Leeson, A. et al. Identifying and managing aqueous film-forming foam-derived per- and polyfluoroalkyl substances in the environment. Env. Toxicol. Chem. 40, 24–36 (2021).
Kassotis, C. D. et al. Endocrine-disrupting chemicals: economic, regulatory, and policy implications. Lancet Diabetes Endocrinol. 8, 719–730 (2020).
Li, J. et al. Per- and polyfluoroalkyl substances exposure and its influence on the intestinal barrier: an overview on the advances. Sci. Total. Env. 852, 158362 (2022).
Helte, E., Säve-Söderbergh, M., Larsson, S. C., Martling, A. & Åkesson, A. Disinfection by-products in drinking water and risk of colorectal cancer: a population-based cohort study. J. Natl Cancer Inst., https://doi.org/10.1093/jnci/djad145 (2023).
Alavanja, M. C. & Bonner, M. R. Occupational pesticide exposures and cancer risk: a review. J. Toxicol. Env. Health B Crit. Rev. 15, 238–263 (2012).
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Polychlorinated Biphenyls and Polybrominated Biphenyls. (IARC: 2016) IARC Monographs vol. 107.
Donato, F. et al. Polychlorinated biphenyls and risk of hepatocellular carcinoma in the population living in a highly polluted area in Italy. Sci. Rep. 11, 3064 (2021).
Vuong, T. P. Research on the relationship between exposure to dioxins and cancer incidence in Vietnam. Toxics 10, 384 (2022).
Steenland, K. & Winquist, A. PFAS and cancer, a scoping review of the epidemiologic evidence. Env. Res. 194, 110690 (2021).
Seachrist, D. D. et al. A review of the carcinogenic potential of bisphenol A. Reprod. Toxicol. 59, 167–182 (2016).
Balali-Mood, M., Naseri, K., Tahergorabi, Z., Khazdair, M. R. & Sadeghi, M. Toxic mechanisms of five heavy metals: mercury, lead, chromium, cadmium, and arsenic. Front. Pharmacol. 12, 643972 (2021).
Chuang, S. C. et al. Phthalate exposure and prostate cancer in a population-based nested case-control study. Env. Res. 181, 108902 (2020).
Lee, W. J. et al. Pesticide use and colorectal cancer risk in the Agricultural Health Study. Int. J. Cancer 121, 339–346 (2007).
Matich, E. K. et al. Association between pesticide exposure and colorectal cancer risk and incidence: a systematic review. Ecotoxicol. Env. Saf. 219, 112327 (2021).
Oddone, E., Modonesi, C. & Gatta, G. Occupational exposures and colorectal cancers: a quantitative overview of epidemiological evidence. World J. Gastroenterol. 20, 12431–12444 (2014).
Kachuri, L., Villeneuve, P. J., Parent, M., Johnson, K. C. & Harris, S. A. Workplace exposure to diesel and gasoline engine exhausts and the risk of colorectal cancer in Canadian men. Env. Health 15, 4 (2016).
Goldberg, M. S. et al. A case–control study of the relationship between the risk of colon cancer in men and exposures to occupational agents. Am. J. Ind. Med. 39, 531–546 (2001).
Talibov, M. et al. Benzene exposure at workplace and risk of colorectal cancer in four Nordic countries. Cancer Epidemiol. 55, 156–161 (2018).
Fang, R., Le, N. & Band, P. Identification of occupational cancer risks in British Columbia, Canada: a population-based case-control study of 1,155 cases of colon cancer. Int. J. Env. Res. Public. Health 8, 3821–3843 (2011).
Alharbi, O. M., Khattab, R. A. & Ali, I. Health and environmental effects of persistent organic pollutants. J. Mol. Liq. 263, 442–453 (2018).
La Merrill, M. A. et al. Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification. Nat. Rev. Endocrinol. 16, 45–57 (2020).
Valvi, D. et al. Environmental chemical burden in metabolic tissues and systemic biological pathways in adolescent bariatric surgery patients: a pilot untargeted metabolomic approach. Env. Int. 143, 105957 (2020).
La Merrill, M. A. et al. Exposure to Persistent Organic Pollutants (POPs) and their relationship to hepatic fat and insulin insensitivity among Asian Indian immigrants in the United States. Env. Sci. Technol. 53, 13906–13918 (2019).
Cano-Sancho, G., Salmon, A. G. & La Merrill, M. A. Association between exposure to p,p’-DDT and its metabolite p,p’-DDE with obesity: integrated systematic review and meta-analysis. Env. Health Perspect. 125, 096002 (2017).
Heindel, J. J. et al. Parma consensus statement on metabolic disruptors. Env. Health 14, 54 (2015).
La Merrill, M. & Birnbaum, L. S. Childhood obesity and environmental chemicals. Mt Sinai J. Med. 78, 22–48 (2011).
La Merrill, M. et al. Toxicological function of adipose tissue: focus on persistent organic pollutants. Env. Health Perspect. 121, 162–169 (2013).
Newbold, R. R., Padilla-Banks, E., Jefferson, W. N. & Heindel, J. J. Effects of endocrine disruptors on obesity. Int. J. Androl. 31, 201–208 (2008).
Giulivo, M., Lopez de Alda, M., Capri, E. & Barceló, D. Human exposure to endocrine disrupting compounds: their role in reproductive systems, metabolic syndrome and breast cancer. A review. Env. Res. 151, 251–264 (2016).
Aseervatham, G. S., Sivasudha, T., Jeyadevi, R. & Arul Ananth, D. Environmental factors and unhealthy lifestyle influence oxidative stress in humans-an overview. Env. Sci. Pollut. Res. Int. 20, 4356–4369 (2013).
Mena, S., Ortega, A. & Estrela, J. M. Oxidative stress in environmental-induced carcinogenesis. Mutat. Res. 674, 36–44 (2009).
Khan, M. F. & Wang, G. Environmental agents, oxidative stress and autoimmunity. Curr. Opin. Toxicol. 7, 22–27 (2018).
Steenland, K., Zhao, L., Winquist, A. & Parks, C. Ulcerative colitis and perfluorooctanoic acid (PFOA) in a highly exposed population of community residents and workers in the mid-Ohio valley. Env. Health Perspect. 121, 900–905 (2013).
Tu, P. et al. Gut microbiome toxicity: connecting the environment and gut microbiome-associated diseases. Toxics 8, 19 (2020).
Song, M. & Chan, A. T. Environmental factors, gut microbiota, and colorectal cancer prevention. Clin. Gastroenterol. Hepatol. 17, 275–289 (2018).
Zolkipli-Cunningham, Z. & Falk, M. J. Clinical effects of chemical exposures on mitochondrial function. Toxicology 391, 90–99 (2017).
Wild, C. P. Complementing the genome with an “exposome”: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol. Biomark. Prev. 14, 1847–1850 (2005).
Walker, D. I. et al. The metabolome: a key measure for exposome research in epidemiology. Curr. Epidemiol. Rep. 6, 93–103 (2019).
Uppal, K. et al. Computational metabolomics: a framework for the million metabolome. Chem. Res. Toxicol. 29, 1956–1975 (2016).
Niedzwiecki, M. M. et al. The exposome: molecules to populations. Annu. Rev. Pharmacol. Toxicol. 59, 107–127 (2019).
Hu, X. et al. A scalable workflow to characterize the human exposome. Nat. Commun. 12, 5575 (2021).
Goodrich, J. A. et al. Exposure to perfluoroalkyl substances and risk of hepatocellular carcinoma in a multiethnic cohort. JHEP Rep. 4, 100550 (2022).
Hu, X. et al. Metabolome wide association study of serum poly and perfluoroalkyl substances (PFASs) in pregnancy and early postpartum. Reprod. Toxicol. 87, 70–78 (2019).
Cohn, B. A. et al. In utero exposure to poly- and perfluoroalkyl substances (PFASs) and subsequent breast cancer. Reprod. Toxicol. 92, 112–119 (2020).
Schreuders, E. H. et al. Colorectal cancer screening: a global overview of existing programmes. Gut 64, 1637–1649 (2015).
Navarro, M., Nicolas, A., Ferrandez, A. & Lanas, A. Colorectal cancer population screening programs worldwide in 2016: an update. World J. Gastroenterol. 23, 3632–3642 (2017).
Chen, H. et al. Participation and yield of a population-based colorectal cancer screening programme in China. Gut 68, 1450–1457 (2019).
Im Shim, J. et al. Results of colorectal cancer screening of the national cancer screening program in Korea, 2008. Cancer Res. Treat. 42, 191–198 (2010).
Cohn, B. A. Developmental and environmental origins of breast cancer: DDT as a case study. Reprod. Toxicol. 31, 302–311 (2011).
Archambault, A. N. et al. Nongenetic determinants of risk for early-onset colorectal cancer. JNCI Cancer Spectr. 5, pkab029 (2021).
Jin, E. H. et al. Association between metabolic syndrome and the risk of colorectal cancer diagnosed before age 50 years according to tumor location. Gastroenterology 163, 637–648.e2 (2022).
Sanford, N. N., Dharwadkar, P. & Murphy, C. C. Early-onset colorectal cancer: more than one side to the story. Colorectal Cancer 9, CRC28 (2020).
Jones, D. P. & Cohn, B. A. A vision for exposome epidemiology: the pregnancy exposome in relation to breast cancer in the Child Health and Development Studies. Reprod. Toxicol. 92, 4–10 (2020).